Study of respiratory infections in infants in Brazil
Part of Infections, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study watches infants in Brazil who are hospitalized or visit a clinic with breathing problems to see if their mother's RSV vaccine helped protect them. It may help doctors understand how well the vaccine works in real life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born in Brazil and you lived in Brazil during pregnancy.
- Your baby was born at least 37 weeks into the pregnancy.
- Your baby is 1 year old or younger when the breathing symptoms start.
- Your baby has been admitted to the hospital or seen at a clinic for at least 24 hours with breathing symptoms (like cough, fast breathing, or trouble feeding).
- Your baby hasn't gotten any other RSV shot or medicine, and hasn't had a blood transfusion since birth.
- You or the baby's legal guardian agree to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a special antibody medicine (called RSV-SMA) to babies aged 6–9 months can help prevent respiratory syncytial virus (RSV), a common virus that causes serious breathing problems in young children. Your baby would receive the medicine and be followed to see if it helps protect them.
This trial tests a new medicine called SIBP-A16 to help protect infants from RSV, a common virus that can cause serious breathing problems. It is for preterm and full-term infants under 1 year old who are entering their first RSV season.
This study tests how your body's immune system responds to a new respiratory syncytial virus (RSV) vaccine. RSV is a common virus that causes respiratory infections, especially in older adults. The vaccine may help protect you from RSV disease.
This study tests an RSV vaccine in adults aged 18 and older, especially those with chronic health issues like heart or lung disease. It aims to see how safe and effective the vaccine is at preventing RSV infections.
This study tracks how respiratory syncytial virus (RSV)—a common respiratory infection in babies—affects children under 24 months in Ho Chi Minh City. Researchers want to understand how often RSV happens, how severe it is, and how it impacts families, so they can better prepare healthcare services.
This study looks at how RSV (a common virus that can affect breathing) leads to illness in young children who come to the doctor with ear infections and/or breathing symptoms. It may help doctors better understand the “burden” RSV causes in both home/outpatient and hospital settings.
Hear when a new Respiratory Syncytial Virus (RSV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.